In acute myeloid leukemia (AML), it has been reported that the degradation of RBM39 represses cassette exon inclusion and promotes intron retention within mRNAs encoding HOXA9 targets and in other RNA-binding proteins (RBPs) preferentially required for AML survival6. Here, RBM39 is linked to acute myeloid leukemia.